Protection of Licensed Patents Clause Samples

Protection of Licensed Patents. (a) KRONOGEN SCIENCES will at all times recognize the ownership of Giampapa of the Licensed Patents and will not at any time do or suffer to be done any act or thing which will in any way impair the rights of Giampapa in the Licensed Patents. KRONOGEN SCIENCES hereby expressly covenants that during the life of this License Agreement and upon and after the termination thereof, KRONOGEN SCIENCES will not claim that its use of the Licensed Patents has created any title in KRONOGEN SCIENCES in any country. (b) During the term of this Agreement, KRONOGEN will pay the fees, if any, associated with the filing, maintenance and prosecution, with the United States Patent and Trademark Office, of the Licensed Patents; provided, however, that Giampapa shall cooperate with KRONOGEN in connection therewith, and provided further, that it is acknowledged and agreed that KRONOGEN shall not be responsible for any fees or other costs or payments associated with any claim or suit relating to the Licensed Patents. (c) In the event of infringement of the Licensed Patents, the parties will jointly cooperate in terminating such infringement.
View SourceView Similar (2)
Protection of Licensed Patents. In the event that Licensee or any Licensee Affiliate becomes aware that: the sole and legitimate ownership of the Licensor in the entire right, title and interest in the Licensed Patents is subject to any challenge, claim or proceeding; or any Licensed Patent is attacked or, being a patent application, is opposed; or any application for a patent is made by or any patent is granted to a third party by reason of which the third party may be granted or may have been granted rights which conflict with any of the rights granted to Licensee under any Licensed Patent; or any unlicensed activities are carried on by any third party which could constitute an infringement of any Licensed Patent; or any application is made for a compulsory licence under any Licensed Patent, Licensee shall forthwith notify Licensor of such matter, and Licensor may, in its discretion, take all such steps as are necessary or desirable for the protection of the Licensed Patents and to maintain the integrity of its ownership. Any expenses and damages incurred in taking such steps shall be for the account of Licensor.
View SourceView Similar (2)
Protection of Licensed Patents. (i) The Product and/or the Active Substance and/or the manufacturing thereof may be protected by one or more patents or patent applications in the name of or licensed to HAMELN or any of its Affiliated Companies. (ii) If LICENSEE obtains information that: (a) a Third Party may infringe any of HAMELN’s Intellectual Property Rights related to the Products in the Territory, or (b) a Third Party intends to file or has filed a patent application or has obtained a patent which may overlap with any of HAMELN’s Intellectual Property Rights in the Territory, LICENSEE shall promptly notify HAMELN thereof. HAMELN will in its sole discretion take such steps as necessary to prosecute such infringement or oppose such conflicting patent application or patent. If such actions would require the cooperation of LICENSEE, LICENSEE shall provide HAMELN with all necessary assistance. HAMELN may reasonably require without charging this to HAMELN except in respect to external costs incurred which had been previously agreed in writing by HAMELN. (iii) The expenses incurred in taking such steps as mentioned under Article 16(ii) and any proceeds which may be obtained out of legal activities against a Third Party infringing HAMELN ´s Intellectual Property Rights related to the Products are, in the absence of agreement to the contrary, for the sole account of HAMELN.
View Source
Protection of Licensed Patents. Patent filing, prosecution, maintenance: UniServices is responsible, in its discretion, for filing, prosecuting and maintaining the Licensed Patents. Costs and expenses incurred by UniServices in the filing, prosecution and maintenance of the Licensed Patents will be met by the Licensee. Obligation to inform: UniServices must, in respect of filing, prosecuting and maintaining the Licensed Patents: (a) keep the Licensee fully and promptly informed of their status; (b) consult with the Licensee on all material respects, including the countries in which patent protection will be sought, reviews of applications, reviews of substantive examination and search reports, and proposed responses; and (c) take into account all reasonable representations made by the Licensee to UniServices in relation to clause 9.2(b).
View Source
Protection of Licensed Patents. (a) Licensee will at all times recognize the ownership of Licensor of the Licensed Patents and will not at any time do or suffer to be done any act or thing which will in any way impair the rights of Licensor in the Licensed Patents. Licensee hereby expressly covenants that during the life of this License Agreement and upon and after the termination thereof, Licensee will not claim that its use of the Licensed Patents has created any title in Licensee in any country. (b) During the term of this Agreement, Licensor will pay the fees, if any, associated with the filing, maintenance and prosecution, with the United States Patent and Trademark Office, of the Licensed Patents; provided, however, that Licensee shall cooperate with Licensor in connection therewith, and provided further, that it is acknowledged and agreed that Licensee shall not be responsible for any fees or other costs or payments associated with any claim or suit relating to the Licensed Patents. Notwithstanding the foregoing, Licensee shall be permitted to file, maintain and prosecute, at it own expense, new patent applications in the name of Licensee in any additional countries which Licensee shall desire, provided the Licensor has not advised Licensee in writing of its prior intention to file in any of such additional countries. (c) In the event of infringement of the Licensed Patents, the parties will jointly cooperate in terminating such infringement.
View Source
Protection of Licensed Patents. 9.1. Patent filing, prosecution, maintenance: UniServices is responsible, acting reasonably and in consultation with the Licensee, for filing, prosecuting and maintaining any registrable Medicinal IP, including submitting any application or lodging any forms and documentations with IP Australia or any other similar body or governmental agency (Registration Obligation). Costs and expenses incurred by UniServices in meeting the Registration Obligations will be met by the Licensee.
View Source
Protection of Licensed Patents. In the event that either party learns of facts which it concludes might constitute an infringement of any of the Licensed Patents by any third party during the term of this Agreement, the party learning of such facts shall promptly notify the other party in writing, setting forth such facts and the basis for its conclusion, and shall include with such notice any other reasonably available evidence in support thereof.
View Source
Protection of Licensed Patents 
View SourceView Similar (6)

Related to Protection of Licensed Patents

  • Licensed Patents Immune Design, at its expense, shall have the first right to file, prosecute and maintain all Licensed Patents for which Immune Design has any exclusive rights under this Agreement using patent counsel reasonably approved by IDRI, including conducting any interferences, reexaminations, reissues, oppositions, or request for patent term extension relating thereto. Immune Design shall conduct such filing, prosecution and maintenance in good faith, taking into consideration IDRI’s retained rights hereunder, and consistent with reasonable business judgment, provide IDRI with all relevant or material documentation and proposed filing in the Territory so that IDRI may be concurrently and promptly informed of the continuing prosecution, and consult with IDRI with regards to Immune Design’s patent strategy with the Licensed Patents for which Immune Design has any exclusive rights under this Agreement. Licensed Patents in the name of IDRI shall remain in the name of IDRI. Immune Design shall use commercially reasonable efforts to ***, as applicable. To the extent such ***, Immune Design shall provide IDRI reasonable opportunity to review and comment on such prosecution efforts regarding such Licensed Patents in the Territory, and any IDRI comments will be reasonably considered in such prosecution efforts, and included to the extent affecting the IDRI Exclusive Field or IDRI Territory, as the case may be. If Immune Design determines in its sole discretion to abandon or not maintain any Licensed Patent for which Immune Design has any exclusive rights under this Agreement in the Territory, then Immune Design shall promptly provide IDRI with written notice of such determination at least sixty (60) days before any deadline for taking action to avoid abandonment and shall provide IDRI with the right, opportunity and reasonable assistance to prepare, file, prosecute and maintain such Licensed Patent in the applicable jurisdiction in IDRI’s sole discretion and at IDRI’s expense, provided that Immune Design shall provide such reasonable assistance at its own costs and expenses. If IDRI elects to prepare, file, prosecute and maintain such Licensed Patent in such jurisdiction for which Immune Design has any exclusive rights, then Immune Design’s license rights to such Licensed Patent in such country will become nonexclusive in such country under such Licensed Patent (and/or patent application). If IDRI desires Immune Design to file, in a particular jurisdiction, a Licensed Patent for which Immune Design has any exclusive rights under this Agreement that claims priority to another Licensed Patent for which Immune Design has any exclusive rights under this Agreement, IDRI shall provide written notice to Immune Design requesting that Immune Design file such patent application in such jurisdiction. If IDRI provides such written notice to Immune Design, Immune Design shall either (i) file and prosecute such patent application and maintain any patent issuing thereon in such jurisdiction and the Parties shall share the related costs and expenses (A) in countries *** on the basis of *** percent (***%) Immune Design: *** percent (***%) IDRI or (B) in countries within the IDRI Territory equally; or (ii) notify IDRI that Immune Design does not desire to file such patent application in such jurisdiction and provide IDRI with the opportunity to file and prosecute such patent application, provided that if IDRI files and prosecutes such patent application in such jurisdiction, then Immune Design’s license rights to such License Patent in such country will become nonexclusive in such country under such Licensed GLA Patent (and/or patent application). Immune Design shall be responsible for the costs and expenses incurred in connection with its own activities for filing, prosecuting and maintaining the Licensed Patents; IDRI shall be responsible for monitoring of such activities by IDRI.

  • ▇▇▇▇▇ of License Georgia Institute of Technology shall grant the Student a limited, nonexclusive, nontransferable and revocable license to use and occupy an assigned space in a Georgia Institute of Technology facility in accordance with the terms and conditions of this Contract (the “License”). The parties to this Contract do not intend that an estate, a tenancy, or any other interest in property should pass from Georgia Institute of Technology to Student. Instead, it is the intention of the parties that the relationship between Georgia Institute of Technology and Student be that of licensor and licensee and the sole right of Student to use the assigned space as a living unit shall be based upon the License granted in this Contract.

  • Grant of License to Use Intellectual Property For the purpose of enabling the Collateral Agent to exercise rights and remedies under this Article at such time as the Collateral Agent shall be lawfully entitled to exercise such rights and remedies, each Grantor hereby grants to the Collateral Agent an irrevocable, non-exclusive license (exercisable without payment of royalty or other compensation to the Grantors) to use, license or sub-license any of the Collateral consisting of Intellectual Property now owned or hereafter acquired by such Grantor, and wherever the same may be located, and including in such license reasonable access to all media in which any of the licensed items may be recorded or stored and to all computer software and programs used for the compilation or printout thereof. The use of such license by the Collateral Agent shall be exercised, at the option of the Collateral Agent, upon the occurrence and during the continuation of an Event of Default; provided that any license, sub-license or other transaction entered into by the Collateral Agent in accordance herewith shall be binding upon the Grantors notwithstanding any subsequent cure of an Event of Default.

  • INTELLECTUAL PROPERTY RIGHTS - INVENTION AND PATENT RIGHTS A. General 1. NASA has determined that 51 U.S.C. § 20135(b) does not apply to this Agreement. Therefore, title to inventions made (conceived or first actually reduced to practice) under this Agreement remain with the respective inventing party(ies). No invention or patent rights are exchanged or granted under this Agreement, except as provided herein.

  • Licensed Patent Rights The Licensee shall indemnify and hold the IC, its employees, students, fellows, agents, and consultants harmless from and against all liability, demands, damages, expenses, and losses, including but not limited to death, personal injury, illness, or property damage in connection with or arising out of: